Indicators

Markets:

News

Latest News about RLMD

Recent news which mentions RLMD

< Previous 1 2 3 Next >

Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2022

October 14, 2022

Why Otonomy Shares Dipped By Around 54%; Here Are 67 Biggest Movers From Yesterday

October 14, 2022

Dow Surges 950 Points; S&P 500 Rises 3%

October 13, 2022

12 Health Care Stocks Moving In Thursday's Intraday Session

October 13, 2022

Why Is Axsome Therapeutics (AXSM) Stock Up Today?

October 13, 2022

Why Laser Photonics Shares Are Trading Higher By Around 44%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session

October 13, 2022

Gold Down 1.5%; Domino's Pizza Shares Spike Higher

October 13, 2022

Why Are Tech Stocks Down Today?

October 13, 2022

Progressive, Asana And Some Other Big Stocks Moving Lower On Thursday

October 13, 2022

Why Is Relmada (RLMD) Stock Down 78% Today?

October 13, 2022

Relmada Stock Tumbles To 52-Week Low On Failed Depression Trial

October 13, 2022

12 Health Care Stocks Moving In Thursday's Pre-Market Session

October 13, 2022

Why Relmada Therapeutics Shares Are Trading Lower By 84%; Here Are 23 Stocks Moving Premarket

October 13, 2022

10 Health Care Stocks Whale Activity In Today's Session

September 20, 2022

The Bull Market Is Still Alive

August 29, 2022

The Bull Market Is Still Alive

August 29, 2022

A Golden Ticket to Beat the Fed and Profit in “Hidden Bull Markets”

August 29, 2022

Earnings Scheduled For August 11, 2022

August 11, 2022

Recap of Tuesday's Biotech Catalysts - End Of the Day Summary

August 09, 2022

Relmada Secures FDA Fast Track Status For Depressive Disorder Candidate

August 09, 2022

10 Biggest Price Target Changes For Monday

May 09, 2022

Relmada Therapeutics Earnings Preview

May 04, 2022

The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy

April 06, 2022

Here's Why Relmada Therapeutics Shares Are Rising

March 24, 2022

Earnings Scheduled For March 23, 2022

March 23, 2022

Relmada Therapeutics's Earnings Outlook

March 22, 2022

Relmada Aces REL-1017 Vs Ketamine Study For Abuse Potential

February 23, 2022

Stocks That Hit 52-Week Lows On Friday

February 04, 2022

The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO

December 09, 2021

Relmada Stock Falls After Equity Raise Of $150M To Fund Depression Candidate

December 09, 2021

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.